Global Complex
Regional Pain
Syndrome Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Complex Regional Pain syndrome (CRPS), which is also known as “reflex sympathetic
dystrophy syndrome” is an uncommon kind of chronic pain condition characterized by
severe pain and inflammation. CRPS develops after an injury, stroke or surgery and the
pain is associated with the severity of the initial injury. CRPS is most common in people of
age group 20-35 and more common in women than men. CRPS is also observed in
children due to their injuries. Excluding the severe pain the other symptoms for CRPS
include swelling and stiffness in joints, changes in the growth of nails, burning sensation
and skin changes in appearance and temperature. Emotional stress can also trigger CRPS
and heighten the pain sensations in an individual.
The complex regional pain syndrome is basically of two types according to the National
Health Service (NHS) U.K, CRPS 1 also called reflex sympathetic dystrophy, it is an
unknown condition resulting from the injury of limb which can also be related to genetics
hence, likely to be a hereditary disorder. CRPS 2 is an extreme severe painful response to
peripheral nerve injury but the pain does not migrate from the original site of injury
unlike CRPS 1. Diagnosis of CRPS depends upon the individual’s medical history and
symptoms as there is no single diagnostic test for it. The incidence rates reveal that
female are three times more affected than male and occurs in the age over 60. According
to a study conducted in U.K, 1 in 3,800 people develop CRPS each year.
Request for sample report: http://www.futuremarketinsights.com/reports/sample/repgb-1708
Report
Description
Report Description
The global market for CRPS is segmented on basis of treatment and distribution channel:
Segmentation by treatment therapies of complex regional pain syndrome
Physical Therapy
Drugs
Analgesics
Antidepressants
Corticosteroids
Others
Surgical sympathectomy
Intrathecal drug pumps
Spinal cord stimulation
Segmentation by distribution channel of complex regional pain syndrome
Pharmacies
Hospitals
Clinics
Research Organizations
Report
Description
Report Description
As CRPS can begin at any age including children, 90% of CRPS occurs if enough care is not
taken by an individual after any serious injury such as fractures, soft tissue injury, limb
immobilization, sprains and surgical procedures. National Institutes of Health (NIH) is
supporting research for CRPS on the brain and CNS by focusing on studying new
approaches in treating CRPS.
On the basis of region prevalence, CRPS is segmented into five key regions: North
America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1708
As it is one of the rare condition there is limited data available for regional market share
for CRPS but there are 50% chances of multiple sclerosis (MS) patients to develop CRPS
and currently North America is one of the leading region in terms of market share
followed by Europe and Asia pacific.
Some of the key market players of the complex regional pain syndrome market include
Mallinckrodt Pharmaceutical, GlaxoSmithKline plc., Mylan N.V., Teva Pharmaceutical
Industries Ltd., AbbVie, ACTAVIS, Zydus Pharmaceuticals, Inc., Sandoz, and Janssen Global
Services, LLC..
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705